BRIEF published on 06/27/2024 at 07:05, 1 year 5 months ago SCHOTT Pharma annonce une croissance robuste au deuxième trimestre de l'exercice 2024 SCHOTT Pharma Expansion Mondiale Solutions À Haute Valeur Ajoutée Hausse Des Revenus T2 2024
PRESS RELEASE published on 06/27/2024 at 07:00, 1 year 5 months ago SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024 SCHOTT Pharma reports 11% revenue growth in Q2 2024, reaffirms guidance for fiscal year. Focus on high-value solutions and expansion. Key figures and strategic developments outlined Financial Results Expansion Revenue Growth SCHOTT Pharma High-value Solutions
BRIEF published on 06/14/2024 at 13:03, 1 year 5 months ago SCHOTT Pharma Opens State-of-the-Art Production Facility in Hungary SCHOTT Pharma Pharmaceutical Trends Hungary Production Facility Glass Syringes
BRIEF published on 06/14/2024 at 13:03, 1 year 5 months ago SCHOTT Pharma ouvre une usine de production de pointe en Hongrie SCHOTT Pharma Usine Hongrie Seringues En Verre Tendances Pharmaceutiques
PRESS RELEASE published on 06/14/2024 at 12:58, 1 year 5 months ago Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary SCHOTT Pharma opens new production facility in Hungary, expanding prefillable glass syringe output to support pharma market growth and trends SCHOTT Pharma Pharma Industry Hungary Production Facility Prefillable Glass Syringes
BRIEF published on 05/14/2024 at 18:24, 1 year 6 months ago SCHOTT Pharma Reaffirms FY 24 Outlook, Anticipates Slower Growth in FY 25 Due to Reduced Syringe Demand Financial Results SCHOTT Pharma FY 24 Forecast FY 25 Growth Impact Syringe Demand Decrease
BRIEF published on 05/14/2024 at 18:24, 1 year 6 months ago SCHOTT Pharma réaffirme ses perspectives pour l’exercice 24 et prévoit un ralentissement de la croissance au cours de l’exercice 25 en raison de la réduction de la demande de seringues Résultats Financiers SCHOTT Pharma Prévisions Pour L'exercice 24 Impact Sur La Croissance Pour L’exercice 25 Diminution De La Demande En Seringues
PRESS RELEASE published on 05/14/2024 at 18:19, 1 year 6 months ago SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes SCHOTT Pharma confirms FY 24 outlook based on Q2 results; FY 25 impacted by slower growth from syringes. H1 24 revenues up 9% at constant currencies Revenue Growth SCHOTT Pharma Syringes FY 24 FY 25
BRIEF published on 05/14/2024 at 18:08, 1 year 6 months ago SCHOTT Pharma Anticipates Fiscal Year 2025 Impact Due to Slower Syringe Sales Revenue Growth EBITDA Margin SCHOTT Pharma Fiscal Year 2025 Syringe Demand
BRIEF published on 05/14/2024 at 18:08, 1 year 6 months ago SCHOTT Pharma anticipe l’impact du ralentissement des ventes de seringues sur l’exercice 2025 SCHOTT Pharma Marge D'EBITDA Hausse Des Revenus Exercice 2025 Demande De Seringues
Published on 12/05/2025 at 15:35, 12 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:00, 47 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 47 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 47 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 15:38, 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 12/05/2025 at 15:36, 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Published on 12/05/2025 at 15:35, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/05/2025 at 15:33, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/05/2025 at 15:32, 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc
Published on 12/05/2025 at 15:10, 36 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 36 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 48 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 2 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 2 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
